# A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors

Source: https://onco.cc/trials/nct02686944/  
OnCo record `nct02686944` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of Ilixadencel run by Mendus, completed.

## Summary

A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors is a phase 1 interventional study registered as NCT02686944 by Mendus, with 6 participants enrolled, started 2016-06-01. Conditions recorded: Gastrointestinal Stromal Tumor. Interventions recorded: Intuvax (ilixadencel).

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02686944
- Phase: 1
- Setting: A Phase I Open-label Study Evaluating Safety and Efficacy of Intratumorally Administered Intuvax in Patients With Progressing Gastrointestinal Stromal Tumors (GIST) During Ongoing Second, Third or Fourth Line Treatment With Tyrosine Kinase Inhibition Therapy. A Prospective Single Armed, Open Label Phase I Safety and Efficacy Study
- Sponsor: Mendus
- Enrolled: 6

## Sources

- ClinicalTrials.gov NCT02686944: https://clinicaltrials.gov/study/NCT02686944

## Connected records

- cancers: [Gastrointestinal stromal tumour (GIST)](https://onco.cc/cancers/gist/)
- drugs: [Ilixadencel](https://onco.cc/drugs/ilixadencel/)
- companies: [Mendus](https://onco.cc/companies/mendus/)

---
JSON: https://onco.cc/api/v1/entities/nct02686944.json